ABSTRACT

Prescription Opioids: Medicare Should Expand Oversight Efforts to Reduce the Risk of Harm, Statement of Elizabeth H. Curda, Director, Health Care, Testimony Before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives   [open pdf - 292KB]

"Misuse of prescription opioids can lead to overdose and death. In 2016, over 14 million Medicare Part D beneficiaries received opioid prescriptions, and spending for opioids was almost $4.1 billion. GAO [Government Accountability Office] and others have reported on inappropriate activities and risks associated with these prescriptions. This statement is based on GAO's October 2017 report (GAO-18-15) and discusses (1) CMS [Centers for Medicare & Medicaid Services] oversight of beneficiaries who receive opioid prescriptions under Part D, and (2) CMS oversight of providers who prescribe opioids to Medicare Part D beneficiaries. For the October 2017 report, GAO reviewed CMS opioid utilization and prescriber data, CMS guidance for plan sponsors, and CMS's strategy to prevent opioid misuse. GAO also interviewed CMS officials, the six largest Part D plan sponsors, and 12 national associations selected to represent insurance plans, pharmacy benefit managers, physicians, patients, and regulatory and law enforcement authorities."

Report Number:
GAO-18-336T
Author:
Publisher:
Date:
2018-01-17
Copyright:
Public Domain
Retrieved From:
Government Accountability Office: http://www.gao.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations